tradingkey.logo

Dental device maker Align's Q3 revenue beats expectations

ReutersOct 29, 2025 8:21 PM


Overview

  • Align Q3 2025 revenue up 1.8% yr/yr, beating analyst expectations

  • Adjusted EPS for Q3 2025 beats consensus, driven by strong international performance

  • Company repurchased 0.5 mln shares at $136.77 average price


Outlook

  • Company expects Q4'25 revenues between $1,025M and $1,045M

  • Align sees Q4'25 GAAP gross margin at 65.5% to 66.0%

  • Company forecasts 2025 Clear Aligner volume growth in mid-single digits


Result Drivers

  • CLEAR ALIGNER VOLUME - Clear Aligner volumes increased 4.9% yr/yr, driven by strength in international markets and growth in the teens and kids segment

  • FOREIGN EXCHANGE IMPACT - Revenue and operating margins were favorably impacted by foreign exchange, contributing $15.6 mln to revenue yr/yr

  • IMAGING SYSTEMS DECLINE - Imaging Systems and CAD/CAM Services revenues fell 0.6% yr/yr due to capital equipment seasonality


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$995.70 mln

$976.33 mln (12 Analysts)

Q3 Adjusted EPS

Beat

$2.61

$2.40 (13 Analysts)

Q3 EPS

$0.78

Q3 Adjusted Net Income

Beat

$189 mln

$172.89 mln (11 Analysts)

Q3 Net Income

$56.80 mln

Q3 Adjusted Operating Income

Beat

$237.80 mln

$206.92 mln (12 Analysts)

Q3 Adjusted Operating Margin

23.90%

Q3 Gross Profit

$639.20 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

  • Wall Street's median 12-month price target for Align Technology Inc is $171.00, about 22.1% above its October 28 closing price of $133.14

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nBwpCKcZa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI